This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stayoussef, M.
Right arrow Articles by Almawi, W. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stayoussef, M.
Right arrow Articles by Almawi, W. Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, February 2008, p. 379-381, Vol. 15, No. 2
1071-412X/08/$08.00+0     doi:10.1128/CVI.00410-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Modulation of Type 1 Diabetes Susceptibility by Tumor Necrosis Factor Alpha –308 G/A and Lymphotoxin Alpha +249 A/G Haplotypes and Lack of Linkage Disequilibrium with Predisposing DQB1-DRB1 Haplotypes in Bahraini Patients{triangledown}

Mouna Stayoussef,1 Fayza A. Al-Jenaidi,2,3 Abduljabbar Al-Abbasi,2,3 Khadija Al-Ola,3 Haya Khayyat,4 Touhami Mahjoub,1 and Wassim Y. Almawi2*

University of Monastir, Monastir, Tunisia,1 College of Medicine and Medical Sciences, Arabian Gulf University,2 Department of Pediatrics, Salmaniya Medical Complex, Manama, Bahrain,3 Bahrain Defense Forces Hospital, Rifaa, Bahrain4

Received 9 October 2007/ Accepted 25 October 2007


arrow
ABSTRACT
 
Tumor necrosis factor alpha (TNF-{alpha}) –308 G/A and lymphotoxin alpha (LT{alpha}) +249 A/G single-nucleotide polymorphisms were investigated in 228 type 1 diabetes mellitus (T1DM) patients and 240 controls. Only LT{alpha} +249G allele and +249G/+249G genotype frequencies were higher among patients, and no linkage disequilibrium was found between TNF-{alpha}/LT{alpha} alleles and susceptible/protective DRB1-DQB1 haplotypes. TNF-{alpha}/LT{alpha} T1DM-susceptible (–308G/+249G) and protective (–308G/+249A) haplotypes were identified.


arrow
TEXT
 
Type 1 (insulin-dependent) diabetes mellitus (T1DM) results from autoimmune destruction of pancreatic β islet cells (1). T1DM susceptibility is determined by environmental, immunologic, and genetic factors (7), including major histocompatibility complex class II genes (2, 11). Other genes lying outside the class II region have also been implicated (7), including the tumor necrosis factor alpha (TNF-{alpha}) and lymphotoxin alpha (LT{alpha}) genes. TNF-{alpha} and LT{alpha} are proinflammatory cytokines involved in T1DM pathogenesis (5, 13), since TNF-{alpha} enhances cytokine-induced β-cell killing (5, 17) and TNF blockade attenuates T1DM development (13). Their expression is under genetic control (10), with several polymorphisms, including TNF-{alpha} –308 G/A and TNF-β +249 A/G single-nucleotide polymorphisms (SNPs), modulating their levels (10).

The association of TNF-{alpha} and LT{alpha} polymorphisms with T1DM was examined, with inconsistent results. TNF-{alpha} –308 G/A SNP was associated with T1DM in some (4, 12, 15), but not all (6, 14), studies. The association of TNF-{alpha} –308 G/A with T1DM was suggested by some (6), but not all (12, 15), studies to be due to its carriage with specific DR-DQ haplotypes. This warrants careful assessment of the involvement of TNF alleles in T1DM due to their close proximity to HLA alleles (6, 15). We investigated whether TNF-{alpha} –308 G/A and LT{alpha} +249 A/G SNPs may be responsible for T1DM susceptibility.

Bahraini study subjects comprised 228 unrelated T1DM patients (109 males and 119 females; mean age, 12.6 ± 8.4 years), diagnosed according to clinical features and laboratory findings. They were receiving insulin for controlling hyperglycemia (with no additional treatment at the time of blood collection), were not obese (mean body mass index = 22.08 ± 7.5), and were free of concomitant complications. Patients with other diabetes forms (type 2, latent autoimmune diabetes in adults, and maturity-onset diabetes of the young, etc.) were excluded. Controls comprised 121 males and 119 females (mean age, 16.3 ± 8.6 years) with normal glucose levels and no family history of T1DM or other autoimmune diseases. All participants were asked to sign a consent form, and all institutional ethics requirements were met.

TNF-{alpha} –308 G/A and LT{alpha} +249 A/G polymorphisms were determined by PCR-restriction fragment length polymorphism analysis using NcoI digestion (8). Allele frequencies were calculated by the gene-counting method, and both polymorphisms were tested for Hardy-Weinberg equilibrium by using the {chi}2 goodness-of-fit test. Allele and genotype frequency differences were tested by Pearson's {chi}2 and Fisher's exact tests, and the two-locus association was assessed as described previously (19). Haplotype estimation was done by the expectation maximization method, whereby the sum of probability estimates for all haplotypes equals 1.0. Regression analysis was determined using HPlus 2.5; results are expressed as P values, odds ratios (OR), and 95% confidence intervals.

Patients and controls were matched for gender and body mass index, with controls being older than patients (P = 0.027). Elevated fasting glucose (P < 0.001) and HbA1c (P < 0.001) levels were seen in patients. Higher incidences of anti-glutamic acid decarboxylase (100/228 patients versus 0/240 controls; P < 0.01), anti-islet cell autoantibodies (83/228 patients versus 0/240 controls; P < 0.001), and combined anti-glutamic acid decarboxylase/islet cell autoantibodies (37/228 patients versus 0/240 controls; P < 0.001) were seen in patients than in controls.

TNF-{alpha} –308 G/A and LT{alpha} +249 A/G distribution was in Hardy-Weinberg equilibrium. LT{alpha} +249G allele and +249 G/G genotype frequencies were higher among patients, while comparable TNF-{alpha} –308 G/A allele and genotype frequencies were seen (Table 1). Linkage disequilibrium (LD) was noted between TNF-{alpha} –308G and LT{alpha} +249A among patients (D' = 0.09; P = 0.001) and between TNF-{alpha} –308A and LT{alpha} +249G among patients (D' = 0.05; P = 0.013) and controls (D' = 0.06; P = 0.001). A higher frequency of the –308G/+249G haplotype and a lower frequency of the –308G/+249A TNF-{alpha}/LT{alpha} haplotype were seen in patients (Table 2). Taking the –308G/+249A TNF-{alpha}/LT{alpha} haplotype as a reference, multivariate regression analysis confirmed the association of the –308G/+249G TNF-{alpha}/LT{alpha} haplotype (P = 0.011; OR = 1.91) with T1DM, after adjusting for a number of covariates.


View this table:
[in this window]
[in a new window]

  		TABLE 1. TNF-{alpha} –308 G/A and LT-{alpha} +249 A/G allele and genotype analysisd


View this table:
[in this window]
[in a new window]

  		TABLE 2. TNF-{alpha} –308 G/A and LT-{alpha} +249 A/G haplotype analysisa

TNF-{alpha} polymorphisms were previously associated with T1DM and type 2 diabetes. TNF-{alpha} –308A and –308A-containing (GA/AA) genotype frequencies were comparable between Bahraini patients and controls, in contrast to studies on non-Caucasian T1DM patients, where an increased frequency of the TNF –308A allele was seen (4, 6, 12). On the other hand, higher LT{alpha} +249G allele and homozygous G/G genotype frequencies were seen in Bahraini patients, in agreement with Japanese (14) and U.S. (Caucasian) (15) studies. Collectively, these differences may be reconciled by ethnicity, diabetes type, population stratification, and sample size.

The selective association of LT{alpha}, more so than TNF-{alpha}, gene variants was demonstrated for some autoimmune diseases (9, 18). Complete LD was seen in our patients between TNF-{alpha} –308 and LT-{alpha} +249A alleles, which was confirmed by haplotype analysis, with LT{alpha} +249G-containing and LT{alpha} +249A-containing haplotypes conferring disease susceptibility and protection, respectively. This was reminiscent of a Moroccan study in which a protective effect of a TNF-{alpha}/LT{alpha} haplotype, independent of LD with HLA class II alleles, was identified (3).

Due its close proximity to HLA genes (7) and because TNF-{alpha} –308 G/A polymorphism was in LD with HLA-DR3 in Europeans (16), it was possible that the contributions of TNF-{alpha} and LT{alpha} polymorphisms to T1DM may by confounded by LD with HLA class II genes, as demonstrated by some (6), but not all (4, 12), studies. It was suggested that disease susceptibility conferred by the TNF-{alpha} –308A allele may be due to its carriage by a stronger DR-DQ haplotype (15). Since no LD was found between TNF-{alpha} and LT{alpha} alleles and high (DRB1*030101 and DQB1*0201)- or low (DRB1*110101 and DQB1*030101)-risk HLA alleles (2), this suggests that the association of the LT{alpha} +249 A/G SNP and TNF-{alpha}/LT{alpha} haplotype with T1DM among Bahraini patients is independent of HLA alleles.

The strengths of this study lie in patient selection (pediatric patients were recruited), thereby excluding the possibility of diabetes misclassification, in the homogeneous ethnicity of the participants (Bahraini Arabs), and in using haplotype analysis, which circumvents the inherent problems of SNP-based association studies. A shortcoming of our study lies in TNF-{alpha} and LT{alpha} SNPs being genotyped, which raises the possibility that other polymorphisms within TNF-{alpha} and LT{alpha} genes may play a more significant role in the population studied. It is important to confirm these findings with additional investigations using high-throughput genotyping methods, which would allow screening of large numbers of samples and thus be powered sufficiently to decrease the probability of false-positive associations. Extended haplotype analyses across these and nearby (HLA) genes are needed to elucidate the contributions of TNF genotypes and haplotypes to T1DM susceptibility.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, P.O. Box 22979, Manama, Bahrain. Phone: 973-39717118. Fax: 973-17271090. E-mail: wyalmawi{at}yahoo.co.uk Back

{triangledown} Published ahead of print on 7 November 2007. Back


arrow
REFERENCES
 
    1
  1. Abiru, N., and G. S. Eisenbarth. 2000. Multiple genes/multiple autoantigens role in type 1 diabetes. Clin. Rev. Allergy Immunol. 18:27-40.[CrossRef][Medline]
    2. 2
  2. Al-Jenaidi, F. A., S. F. Wakim-Ghorayeb, A. Al-Abbasi, M. R. Arekat, N. Irani-Hakime, P. Najm, K. Al-Ola, A. A. Motala, and W. Y. Almawi. 2005. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab. 90:5104-5109.[Abstract/Free Full Text]
    3. 3
  3. Bouqbis, L., O. Akhayat, H. J. Garchon, F. Calafell, and H. Izaabel. 2003. TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population. Tissue Antigens 61:72-79.[CrossRef][Medline]
    4. 4
  4. Cheong, K. Y., R. J. Allcock, P. Eerligh, C. S. Witt, F. T. Christiansen, V. McCann, and P. Price. 2001. Localization of central MHC genes influencing type I diabetes. Hum. Immunol. 62:1363-1370.[CrossRef][Medline]
    5. 5
  5. Cnop, M., N. Welsh, J. C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54:S97-S107.[Abstract/Free Full Text]
    6. 6
  6. Deng, G. Y., N. K. Maclaren, H. S. Huang, L. P. Zhang, and J. X. She. 1996. No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum. Immunol. 45:137-142.[CrossRef][Medline]
    7. 7
  7. Dotta, F., C. Fondelli, and U. Di Mario. 2005. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction. Acta Biomed. 76(Suppl. 3):14-18.[Medline]
    8. 8
  8. Fanning, G. C., M. Bunce, C. M. Black, and K. I. Welsh. 1997. Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 50:23-31.[Medline]
    9. 9
  9. Fernandes Filho, J. A., C. A. Vedeler, K. M. Myhr, H. Nyland, and J. P. Pandey. 2002. TNF-{alpha} and -β gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-β gene. Autoimmunity 35:377-380.[CrossRef][Medline]
    10. 10
  10. Hajeer, A. H., and I. V. Hutchinson. 2000. TNF-alpha gene polymorphism: clinical and biological implications. Microsc. Res. Tech. 50:216-228.[CrossRef][Medline]
    11. 11
  11. Kockum, I., C. B. Sanjeevi, S. Eastman, M. Landin-Olsson, G. Dahlquist, and A. Lernmark. 1999. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur. J. Immunogenet. 26:361-372.[CrossRef][Medline]
    12. 12
  12. Kumar, R., R. Goswami, S. Agarwal, N. Israni, S. K. Singh, and R. Rani. 2007. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 69:557-567.[CrossRef][Medline]
    13. 13
  13. McDevitt, H., S. Munson, R. Ettinger, and A. Wu. 2002. Multiple roles for tumor necrosis factor-{alpha} and lymphotoxin {alpha}/β in immunity and autoimmunity. Arthritis Res. 4:S141-S152.[CrossRef][Medline]
    14. 14
  14. Nishimura, M., H. Obayashi, I. Mizuta, H. Hara, T. Adachi, M. Ohta, H. Tegoshi, M. Fukui, G. Hasegawa, H. Shigeta, Y. Kitagawa, K. Nakano, R. Kaji, and N. Nakamura. 2003. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum. Immunol. 64:302-309.[CrossRef][Medline]
    15. 15
  15. Noble, J. A., A. M. Valdes, J. A. Lane, A. E. Green, and H. A. Erlich. 2006. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum. Immunol. 67:999-1004.[CrossRef][Medline]
    16. 16
  16. Pociot, F., L. Briant, C. V. Jongeneel, J. Molvig, H. Worsaae, M. Abbal, M. Thomsen, J. Nerup, and A. Cambon-Thomsen. 1993. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-{alpha} and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:224-231.[Medline]
    17. 17
  17. Rabinovitch, A., and W. L. Suarez-Pinzon. 2003. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev. Endocr. Metab. Disord. 4:291-299.[CrossRef][Medline]
    18. 18
  18. Skeie, G. O., J. P. Pandey, J. A. Aarli, and N. E. Gilhus. 1999. TNFA and TNFB polymorphisms in myasthenia gravis. Arch. Neurol. 56:457-461.[Abstract/Free Full Text]
    19. 19
  19. Svejgaard, A., and L. P. Ryder. 1994. HLA and disease associations: detecting the strongest association. Tissue Antigens 43:18-27.[Medline]

Clinical and Vaccine Immunology, February 2008, p. 379-381, Vol. 15, No. 2
1071-412X/08/$08.00+0     doi:10.1128/CVI.00410-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stayoussef, M.
Right arrow Articles by Almawi, W. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stayoussef, M.
Right arrow Articles by Almawi, W. Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»